Your browser doesn't support javascript.
loading
Translational findings for odronextamab: From preclinical research to a first-in-human study in patients with CD20+ B-cell malignancies.
Zhu, Min; Olson, Kara; Kirshner, Jessica R; Khaksar Toroghi, Masood; Yan, Hong; Haber, Lauric; Meagher, Craig; Flink, Dina M; Ambati, Srikanth R; Davis, John D; DiCioccio, A Thomas; Smith, Eric J; Retter, Marc W.
Afiliación
  • Zhu M; Department of Pharmacometrics, Regeneron Pharmaceuticals, Inc., Tarrytown, New York, USA.
  • Olson K; Department of Research, Regeneron Pharmaceuticals, Inc., Tarrytown, New York, USA.
  • Kirshner JR; Department of Research, Regeneron Pharmaceuticals, Inc., Tarrytown, New York, USA.
  • Khaksar Toroghi M; Department of Pharmacometrics, Regeneron Pharmaceuticals, Inc., Tarrytown, New York, USA.
  • Yan H; Department of Pharmacometrics, Regeneron Pharmaceuticals, Inc., Tarrytown, New York, USA.
  • Haber L; Department of Research, Regeneron Pharmaceuticals, Inc., Tarrytown, New York, USA.
  • Meagher C; Department of Research, Regeneron Pharmaceuticals, Inc., Tarrytown, New York, USA.
  • Flink DM; Department of Clinical Development, Regeneron Pharmaceuticals, Inc., Tarrytown, New York, USA.
  • Ambati SR; Department of Clinical Development, Regeneron Pharmaceuticals, Inc., Tarrytown, New York, USA.
  • Davis JD; Department of Pharmacometrics, Regeneron Pharmaceuticals, Inc., Tarrytown, New York, USA.
  • DiCioccio AT; Department of Pharmacometrics, Regeneron Pharmaceuticals, Inc., Tarrytown, New York, USA.
  • Smith EJ; Department of Research, Regeneron Pharmaceuticals, Inc., Tarrytown, New York, USA.
  • Retter MW; Department of Pharmacometrics, Regeneron Pharmaceuticals, Inc., Tarrytown, New York, USA.
Clin Transl Sci ; 15(4): 954-966, 2022 04.
Article en En | MEDLINE | ID: mdl-34997701
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Linfoma de Células B / Anticuerpos Biespecíficos / Antineoplásicos Tipo de estudio: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Animals / Humans Idioma: En Revista: Clin Transl Sci Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Linfoma de Células B / Anticuerpos Biespecíficos / Antineoplásicos Tipo de estudio: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Animals / Humans Idioma: En Revista: Clin Transl Sci Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos